Villamor, Erlinda N.

HRN: 20-49-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
ACICLOVIR 800MG (TAB)
06/13/2022
06/17/2022
PO
800
Q6
Herpes Zoster
Waiting Final Action 
06/21/2022
CEFTRIAXONE 1G (VIAL)
06/21/2022
06/28/2022
IV
2gm
OD
Sepsis
Waiting Final Action 
06/22/2022
LEVOFLOXACIN 500MG (TAB)
06/22/2022
06/29/2022
ORAL
750mg
OD
Septicemia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: